<DOC>
	<DOCNO>NCT01771406</DOCNO>
	<brief_summary>The aim study examine effective CPAP treatment treatment nebivolol respectively reduce blood pressure endothelial dysfunction patient suffer obstructive sleep apnea hypertension .</brief_summary>
	<brief_title>CPAP Nebivolol Hypertensive Obstructive Sleep Apnea ( OSA ) Patients .</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>male/female ≥ 18 year old patient obstructive sleep apnea ( apneahypopnea index ≥ 20 ) naïve CPAP treatment patient weak moderate hypertension ( 140 &lt; = systolic blood pressure ( SBP ) &lt; 180 mmHg 90 &lt; = diastolic blood pressure ( DBP ) &lt; 110 mmHg naïve antihypertensive treatment negative pregnancy test ambulatory patient patient sign informed consent form patient affiliate social security pregnant nursing woman acute hepatic failure , biliary cirrhosis , cholestasis clearance Cockcroft &lt; 30 ml/min/1.73m2 sick sinus syndrome , include sinoatrial block second third degree heart block ( without pacemaker ) history bronchospasm bronchial asthma bradycardia ( heart rate &lt; 60bpm prior start therapy ) severe peripheral circulatory disturbance acute hypertension ( SBP &gt; = 180 mmHg and/or DBP &gt; = 110 mmHg ) severe daytime sleepiness ( Epworth rating scale &gt; 15 ) know cardiovascular pathology contraindication CPAP allergy nebivolol patient treat antihypertensive drug ( ) , class I antiarrhythmics ( quinidine , hydroquinidine , cibenzoline , flecainide , disopyramide , lidocaine , mexiletine , propafenone ) patient treat CPAP patient keep detention , major protect law , hospitalise person patient currently participate another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>